6 nominees · 3 ballot items.
Shareholders will elect six directors, ratify Ernst & Young LLP as independent auditor, and approve on a non-binding advisory basis the 2025 compensation of the named executive officers.
Elect Rajiv Basu, Matthew B. Botein, Joel D. Cavaness, Frank N. D’Orazio, Christine LaSala, and Peter B. Migliorato to serve as directors until the 2027 annual meeting and until their successors are elected and qualified.
Ratify the Audit Committee’s appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm to serve until the 2027 annual meeting.
Approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis, Summary Compensation Table, and related tables.
Proposal 3 asks shareholders to approve, on a non-binding advisory basis, the overall 2025 compensation of the named executive officers as disclosed in the proxy statement. It is not a vote on any single compensation element, but on the aggregate program and its underlying philosophy, policies, and practices. Management says the program is intended to provide competitive compensation that attracts, motivates, and retains executives in the specialty insurance industry. The program also seeks to align executives with shareholders through service-based and performance-based equity awards. Annual incentives are linked to financial and strategic goals, while long-term awards include performance restricted share units and service-based restricted share units. The filing emphasizes that approximately 67% of the CEO’s 2025 target compensation and 64% of the average target compensation of other continuing NEOs was variable and at risk. The Company reports that 2025 performance produced below-target outcomes for several incentive metrics and that the 2023–2025 PRSUs settled at 73% of target, which management presents as evidence of pay-for-performance alignment. The Company also describes shareholder engagement following the prior year’s 63.4% say-on-pay approval, including feedback concerning retention awards, discretionary adjustments, disclosure of performance targets, and pay-performance alignment. In response, the Board approved higher 2026 incentive opportunities for the CEO and an increased long-term incentive opportunity for the Chief Legal Officer, while stating that one-time awards will be limited and judicious. The Board recommends voting FOR the proposal because it believes the compensation program is competitive, performance-oriented, aligned with long-term shareholder value, and responsive to shareholder feedback; the vote remains advisory and non-binding.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Gallatin Point Capital LLC | 12.67% | 5,859,375 | $26M |
| 2 | Zimmer Partners, LP | 10.00% | 4,623,685 | $20M |
| 3 | T. Rowe Price Investment Management, Inc. | 9.96% | 4,605,838 | $20M |
| 4 | CONTINENTAL GENERAL INSURANCE CO | 5.64% | 2,607,587 | $11M |
| 5 | Enstar Group LTD | 5.60% | 2,590,765 | $11M |
| 6 | DONALD SMITH CO., INC. | 5.28% | 2,440,347 | $11M |
| 7 | BlackRock, Inc. | 3.73% | 1,725,020 | $8M |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 3.73% | 1,724,161 | $8M |
| 9 | BlackRock, Inc. | 2.97% | 1,374,877 | $6M |
| 10 | RBF Capital, LLC | 2.64% | 1,221,980 | $5M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.